Proposal:TRANSPLANT Act of 2021

This proposal's bill was enacted into law, so the proposal is archived and closed to further debate. See the resulting project: Project:TRANSPLANT Act of 2021.

Bill	S 288
Type of Legislation	Senate Bill
Congress	117
Status	Archived — enacted into law
Linked Project	Project:TRANSPLANT Act of 2021
Source	View original on Congress.gov

Geographic Scope

National

Description

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.

The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

In addition, the Government Accountability Office must report on the regenerative medicine workforce.

Bill Title

TRANSPLANT Act of 2021

Linked Project

• Project:TRANSPLANT Act of 2021

Linked Goals

• Goal:Promote General Welfare

Steps

• 2021-02-08: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S575)
• 2021-02-08: Introduced in Senate

Projected Outcome

A more informed proposal or public response aligned with the Promote General Welfare goal.